| Ronald Dela Villareal, MD | |
|
1129 Northern Blvd, 101, Manhasset, NY 11030-3045 | |
| (516) 365-5570 | |
| (516) 365-5532 |
| Full Name | Ronald Dela Villareal |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 24 Years |
| Location | 1129 Northern Blvd, Manhasset, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689859266 | NPI | - | NPPES |
| 2010864902 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heights Nephrology Medical Group Pc | 8729979166 | 5 |
News Archive
A new study has shown that the airborne transmission of COVID-19 is highly random and suggests that the two-meter rule was a number chosen from a risk 'continuum', rather than any concrete measurement of safety.
The U.N. General Assembly will move to formally adopt a new "gender entity" on Friday called "U.N. Women" that will fold the U.N.'s four existing women's entities - UNIFEM, the Office of the Special Adviser on Gender Issues, the U.N. Division for the Advancement of Women and INSTRAW - into one, Inter Press Service reports.
This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.
ECRI, a nonprofit health services research agency, recently published a Health Technology Forecast profile on a novel pharmaceutical agent that is in development for the treatment of obesity.
› Verified 2 days ago
| Entity Name | Heights Nephrology Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770500100 PECOS PAC ID: 8729979166 Enrollment ID: O20040323001995 |
News Archive
A new study has shown that the airborne transmission of COVID-19 is highly random and suggests that the two-meter rule was a number chosen from a risk 'continuum', rather than any concrete measurement of safety.
The U.N. General Assembly will move to formally adopt a new "gender entity" on Friday called "U.N. Women" that will fold the U.N.'s four existing women's entities - UNIFEM, the Office of the Special Adviser on Gender Issues, the U.N. Division for the Advancement of Women and INSTRAW - into one, Inter Press Service reports.
This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.
ECRI, a nonprofit health services research agency, recently published a Health Technology Forecast profile on a novel pharmaceutical agent that is in development for the treatment of obesity.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald Dela Villareal, MD 1129 Northern Blvd, Ste. 101, Manhasset, NY 11030-3045 Ph: (516) 365-5570 | Ronald Dela Villareal, MD 1129 Northern Blvd, 101, Manhasset, NY 11030-3045 Ph: (516) 365-5570 |
News Archive
A new study has shown that the airborne transmission of COVID-19 is highly random and suggests that the two-meter rule was a number chosen from a risk 'continuum', rather than any concrete measurement of safety.
The U.N. General Assembly will move to formally adopt a new "gender entity" on Friday called "U.N. Women" that will fold the U.N.'s four existing women's entities - UNIFEM, the Office of the Special Adviser on Gender Issues, the U.N. Division for the Advancement of Women and INSTRAW - into one, Inter Press Service reports.
This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.
ECRI, a nonprofit health services research agency, recently published a Health Technology Forecast profile on a novel pharmaceutical agent that is in development for the treatment of obesity.
› Verified 2 days ago
Samit Shah, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-1427 | |
William J Berger, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1201 Northern Blvd Ste 201, Manhasset, NY 11030 Phone: 516-488-4428 Fax: 516-328-2723 | |
Lawrence Ong, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: Nsuh Dept Of Medicine Cardiology, 300 Community Drive, Manhasset, NY 11030 Phone: 516-562-4103 | |
Dr. Malcolm E Levine, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1201 Northern Blvd, Manhasset, NY 11030 Phone: 516-627-1221 Fax: 516-627-6857 | |
Dr. Angela C Kim, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-4280 Fax: 516-975-4994 | |
Dr. Roseann M Russo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1165 Northern Blvd, Suite 300, Manhasset, NY 11030 Phone: 516-608-6820 Fax: 516-608-6821 | |
Dr. Zahava Farkas, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 444 Community Dr Ste 302, Manhasset, NY 11030 Phone: 516-387-6826 |